-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TOUR-006 in Graves’ Ophthalmopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TOUR-006 in Graves' Ophthalmopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TOUR-006 in Graves' Ophthalmopathy Drug Details: TOUR-006 is under development for thyroid...
-
Sector Analysis
Eastern Europe Foodservice Market Size and Trends by Profit and Cost Sector Channels, Players and Forecast to 2027
Eastern Europe Foodservice Market Report Overview The Eastern Europe foodservice profit sector recorded sales of $80.1 billion in 2022 and is forecast to record a strong CAGR of over 20% during 2022-2027. The Eastern European foodservice industry is witnessing a surge in the adoption of vegan and plant-based diets by consumers. Thus, plant-based menus, featuring innovative alternatives to traditional dishes are becoming increasingly popular. Additionally, restaurants and cafes across the region are increasingly adopting eco-friendly practices to minimize their environmental...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Linsitinib in Graves’ Ophthalmopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Linsitinib in Graves' Ophthalmopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Linsitinib in Graves' Ophthalmopathy Drug Details: Linsitinib (OSI906, ASP7487) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TOUR-006 in Graves’ Ophthalmopathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TOUR-006 in Graves' Ophthalmopathy Drug Details: TOUR-006 is under development for thyroid eye disease (TED) and atherosclerotic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lonigutamab Ugodotin in Graves’ Ophthalmopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lonigutamab Ugodotin in Graves' Ophthalmopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Lonigutamab Ugodotin in Graves' Ophthalmopathy Drug Details:VB-421 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LASN-01 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LASN-01 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LASN-01 in Idiopathic Pulmonary Fibrosis Drug Details:LASN-01 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SAR-441169 in Psoriasis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SAR-441169 in Psoriasis Drug Details:SAR-441169 is under development for the treatment of autoimmune diseases including rheumatoid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cytisinicline in Smoking Cessation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cytisinicline in Smoking Cessation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Cytisinicline in Smoking CessationDrug Details:Cytisinicline (Tabex) is under development for the treatment of...
-
Sector Analysis
United Kingdom (UK) Childrenswear Market Size and Trend Analysis by Category, Segments, Region, Key Brands, and Forecast to 2027
UK Childrenswear Market Overview The United Kingdom (UK) childrenswear market was valued at £6.5 billion in 2023. The market is expected to grow at a CAGR of more than 1% from 2023 to 2027. The UK childrenswear market to 2027 report offers comprehensive insight and analysis of the UK childrenswear market, the major players, the key trends, and consumer attitudes. It provides a detailed analysis of the key trends shaping the market, market sizes and forecasts, and the performance of...